454
J. Wölfling et al. / Steroids 68 (2003) 451–458
3g (185 mg, 86%) mp 73–76 ◦C, Rf = 0.25 (ss D); [␣]2D0+
tracted with dichloromethane, and the dichloromethane solu-
tion was washed with water, dried (Na2SO4) and evaporated.
The residue was subjected to chromatographic separation on
a silica gel column with dichloromethane as eluent. Product
5 eluted first as an oil. Rf = 0.39 (ss D); [␣]20 + 68 (c 1)
(Found: C, 80.38; H, 8.85%. C20H26O2 requiDres C, 80.50;
H, 8.78%); 1H NMR (C6D6, δ [ppm]): 0.91 (s, 3H, 18-H3),
1.02 (m, 1H, 14-H), 1.07 and 1.82 (2× m, 2× 1H, 12-H2),
1.09 and 2.00 (2× m, 2× 1H, 7-H2), 1.27 and 2.00 (2× m,
2× 1H, 11-H2), 1.58 (m, 1H, 8-H), 2.11 (m, 1H, 9-H), 2.19
and 2.27 (2× m, 2× 1H, 15-H2), 2.66 (m, 2H, 6-H2), 3.42
(s, 3H, 3-OMe), 4.92 and 4.95 (2× m, 2× 1H, 16␣-H2),
5.69 (m, 1H, 16-H), 6.66 (d, 1H, J = 2.6 Hz, 4-H), 6.79 (dd,
1H, J = 8.6, 2.6 Hz, 2-H), 7.07 (d, 1H, J = 8.6 Hz, 1-H),
9.48 (s, 1H, formyl-H). 13C NMR (C6D6, δ [ppm]): 23.5
(C-18), 28.2 (C-11), 28.3 (C-7), 30.9 (C-6), 34.1 (C-15),
36.9 (C-12), 42.9 (C-8), 44.0 (C-9), 49.9 (C-14), 50.4 (C-13),
55.2 (3-OCH3), 112.6 (C-2), 114.2 (C-4), 115.3 (C-16␣),
127.2 (C-1), 132.6 (C-10), 138.3 (C-5), 140.3 (C-16), 158.8
(C-3), 205.9 (C-formyl). MS (70 eV); m/z (%): 298 (100,
M+), 213 (42), 173 (22), 147 (21), 115 (9), 91 (10). Con-
tinued elution yielded 6. mp 85–88 ◦C, Rf = 0.31 (ss A);
[␣]2D0 + 71 (c 1) (Found: C, 80.63; H, 8.86%. C20H26O2 re-
62 (c 1) (Found: C, 62.85; H, 7.04%. C22H29BrO3 requires
C, 62.71; H, 6.94%); 1H NMR δ (ppm) 1.10 (s, 3H, 18-Me),
2.01 (s, 3H, Ac-Me), 2.82 (m, 2H, 6-H2), 3.43 (dd, 1H, J =
9.7, 8.1 Hz) and 3.64 (dd, 1H, J = 9.8, 5.4 Hz): 16␣-H2,
3.77 (s, 3H, 3-OMe), 4.72 (d, 1H, J = 5.4 Hz, 17␣-H), 6.62
(d, 1H, J = 2.6 Hz, 4-H), 6.72 (dd, 1H, J = 8.6, 2.6 Hz,
2-H), 7.19 (d, 1H, J = 8.6 Hz, 1-H). 13C NMR δ (ppm)
21.3 (Ac-CH3), 28.4, 29.0, 30.0 (C-18), 30.4, 32.2, 33.1,
36.8, 40.6, 40.7, 44.4 (C-13), 47.9, 51.8, 55.2 (3-OCH3),
85.8 (C-17), 111.9 (C-2), 113.4 (C-4), 127.2 (C-1), 132.6
(C-10), 138.1 (C-5), 157.4 (C-3), 170.8 (Ac-CO).
3h (195 mg, 84%) oil, Rf = 0.23 (ss C); [␣]2D0 + 51 (c 1)
(Found: C, 56.62; H, 6.08%. C22H29IO3 requires C, 56.42;
1
H, 6.24%); H NMR δ (ppm) 1.11 (s, 3H, 18-H3), 2.01 (s,
3H, Ac-Me), 2.82 (m, 2H, 6-H2), 3.20 (t, 1H, J = 8.9 Hz)
and 3.45 (dd, 1H, J = 9.6, 5.5 Hz): 16␣-H2, 3.77 (s, 3H,
3-OMe), 4.65 (d, 1H, J = 5.5 Hz, 17␣-H), 6.62 (d, 1H, J =
2.6 Hz, 4-H), 6.72 (dd, 1H, J = 8.6, 2.6 Hz, 2-H), 7.18 (d,
1H, J = 8.6 Hz, 1-H). 13C NMR δ (ppm) 10.4 (C-16␣), 21.3
(Ac-CH3), 28.4, 28.9, 30.1 (C-18), 30.4, 33.0, 34.4, 40.6,
40.7, 44.8 (C-13), 48.0, 51.8, 55.2 (3-OCH3), 86.7 (C-17),
111.9 (C-2), 113.4 (C-4), 127.2 (C-1), 132.7 (C-10), 138.1
(C-5), 157.4 (C-3), 170.8 (Ac-CO). MS (70 eV); m/z (%):
468 (100, M+), 281 (7), 186 (13), 173 (18), 147 (17), 86
(10), 43 (23).
1
quires C, 80.50; H, 8.78%); H NMR δ (ppm) 0.94 (s, 3H,
18-H3), 2.78 (m, 2H, 6-H2), 3.75 (s, 3H, 3-OMe), 3.94 (s,
1H, 17␣-H), 5.06 and 5.18 (2× s, 2× 1H, 16␣-H2), 6.58 (d,
1H, J = 2.6 Hz, 4-H), 6.70 (dd, 1H, J = 8.6, 2.6 Hz, 2-H),
7.19 (d, 1H, J = 8.6 Hz, 1-H). 13C NMR δ (ppm) 28.9, 29.3,
29.7 (C-18), 30.5, 32.4, 34.1, 40.7, 42.5, 43.9 (C-13), 50.6,
55.2 (3-OCH3), 84.1 (C-17), 110.1 (C-16␣), 111.8 (C-2),
113.5 (C-4), 127.3 (C-1), 133.1 (C-10), 138.2 (C-5), 155.8
(C-16), 157.3 (C-3). MS (70 eV); m/z (%): 298 (100, M+),
227 (37), 186 (7), 173 (11), 147 (10), 91 (3), 43 (4). Finally
eluted 8. Oil, Rf = 0.38 (ss B); [␣]2D0 +102 (c 1) (Found: C,
76.21; H, 9.27%. C21H30O3 requires C, 76.33; H, 9.15%);
1H NMR δ (ppm) 1.08 (s, 3H, 18-H3), 2.74 (m, 2H, 6-H2),
3.34 (s, 3H, 16␣-OMe), 3.39 (t, 1H, J = 8.0 Hz, 16␣-H),
3.50 (m, 2H, 16␣-H, and 17␣-H), 3.74 (s, 3H, 3-OMe), 6.56
(d, 1H, J = 2.7 Hz, 4-H), 6.69 (dd, 1H, J = 8.6, 2.7 Hz,
2-H), 7.13 (d, 1H, J = 8.6 Hz, 1-H). 13C NMR δ (ppm)
27.6, 28.2, 28.9 (C-18), 29.0, 29.4, 30.4, 38.0, 41.1, 43.6
(C-13), 45.0, 50.3, 55.2 (3-OCH3), 59.1 (16␣-OCH3), 77.0
(C-16␣), 86.3 (C-17), 112.1 (C-2), 113.2 (C-4), 127.7 (C-1),
134.1 (C-10), 137.9 (C-5), 157.2 (C-3) (Table 1).
3i (222 mg, 87%) mp 124–125 ◦C, Rf = 0.15 (ss E);
[␣]2D0 + 17 (c 1) (Found: C, 68.12; H, 7.17%. C29H36O6S
1
requires C, 67.94; H, 7.08%); H NMR δ (ppm) 1.00 (s,
3H, 18-H3), 1.96 (s, 3H, Ac-Me), 2.45 (s, 3H, Ts-Me), 2.81
(m, 2H, 6-H2), 3.78 (s, 3H, 3-OMe), 4.07 (dd, 1H, J = 9.7,
7.3 Hz) and 4.17 (dd, 1H, J = 9.7, 5.4 Hz): 16␣-H2, 4.60
(d, 1H, J = 5.4 Hz, 17␣-H), 6.62 (d, 1H, J = 2.8 Hz, 4-H),
6.72 (dd, 1H, J = 8.6, 2.8 Hz, 2-H), 7.18 (d, 1H, J = 8.6 Hz,
1-H), 7.35 (d, 2H, J = 8.0 Hz, 3ꢀ,5ꢀ-H), 7.79 (dd, 2H, J =
6.6, 1.7 Hz, 2ꢀ,6ꢀ-H). 13C NMR δ (ppm) 21.2 (Ac-CH3), 21.6
(Ts-CH3), 28.4, 29.0, 29.7, 29.8 (C-18), 30.4, 32.9, 40.4,
40.6, 44.0 (C-13), 45.2, 51.7, 55.2 (3-OCH3), 72.3 (C-16␣),
83.9 (C-17), 111.9 (C-2), 113.4 (C-4), 127.2 (C-1), 127.9
(2C, C-2ꢀ,6ꢀ), 129.8 (2C, C-3ꢀ,5ꢀ), 132.6 (C-10), 133.0 (C-1ꢀ),
138.1 (C-5), 144.7 (C-4ꢀ), 157.4 (C-3), 170.7 (Ac-CO). MS
(70 eV); m/z (%): 512 (100, M+), 452 (6), 280 (11), 186
(16), 173 (13), 91 (8), 43 (8).
2.7. 3-Methoxy-16,17-seco-13α-estra-1,3,5(10),
16-tetraen-17-al (5), 3-methoxy-16-methylene-
13α-estra-1,3,5(10)-trien-17β-ol (6) and
3-methoxy-16α-methoxymethyl-13α-estra-
1,3,5(10)-trien-17β-ol (8)
Table 1
Yields of the products (5, 6, 8) formed by alkaline solvolysis of the differ-
ent 16-halomethyl- or 16-tosyloxymethyl-17-hydroxy compounds (3b–e)
Starting material
Products (%)
2.7.1. General procedure
5
6
8
Compound 3b, 3c, 3d, or 3e (1 mmol) was dissolved
in methanol (15 ml) and heated under reflux with KOH
(280 mg, 5 mmol) for 3 h. The reaction mixture was next
poured into water and neutralized with 10% hydrochloric
acid, and the precipitate was filtered off. The mixture was ex-
3b
3c
3d
3e
65
71
79
73
12
11
10
11
6
6
5
6